Pulse nav.journalClub 活発な議論トレンド探索研究者

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

ホーム探索 nav.journalClub トレンド

⌘+K

© Synapse Social LLC, 2026

プライバシーポリシー

May 6, 2024

Twists and turns of diabetology - immune checkpoint inhibitor-mediated diabetes

Key Points

Key points are not available for this paper at this time.

Abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

AIに質問

Like

Bookmark

Share

Cite This Study

Majic et al. (Mon,) studied this question.

synapsesocial.com/papers/68e6b6eab6db643587638496 https://doi.org/https://doi.org/10.1530/endoabs.99.ep788

AIに質問

Like

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Immune checkpoint inhibitor-associated diabetes mellitus2024
2Analysis of autoimmunity to the insulin-receptor in diabetes mellitus2024
3Immunotherapy-induced endocrinopathies: unraveling a clinical case of immune-mediated diabetes firstly and thyroid pathology secondly2024 · 1 citations
4A case of type 2 diabetes masked by insulinoma2024
5Immunotherapy induced endocrinopathies2024

糖尿病学の変遷 - 免疫チェックポイント阻害剤による糖尿病 | Synapse